Clinical Trial Update: 18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques [Phase 4]

View source ↗

Summary

Phase 4 trial update on using 18F-fluoride PET to identify coronary atherosclerotic plaques.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Plaque
• Coronary Artery Disease

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Coronary Artery Disease, Atherosclerotic Plaque | Phase 4 | Status: COMPLETED